MTOP in general practice

Posted Wednesday 27 November 2024 | Qld Health

For general practitioners, pharmacists, nurse practitioners, endorsed midwives, and other registered health practitioners.

The termination of Pregnancy Act was passed in 2018 and has been an integral step in enabling women and pregnant people safe access to termination healthcare. On 11 July 2023, the Therapeutic Goods Administration (TGA) regulations announced from the 1 August 2023, changes will be made to the prescribing and dispensing requirements for MS-2 Step. MS-2 Step (Mifepristone and Misoprostol) is the early medical termination of pregnancy medication used in Australia.

Join experienced MS-2 Step prescriber Dr Mark Raines and other experienced clinicians, to hear what these changes mean for you. Learn how to become and what it means to be a MS-2 Step prescriber and take the opportunity to discuss with your colleagues the challenges and benefits of being a MS-2 Step prescriber.

This session can be attended virtually by selecting the videoconference option at the time of registration.

Light refreshments will be provided.